U.S. Markets close in 2 hrs 30 mins

TSO3 Announces the Vote Results from its Annual Meeting of the Shareholders

QUEBEC CITY and MYRTLE BEACH, SC, May 8, 2019 /PRNewswire/ - TSO3 Inc. (TOS.TO), ("TSO3" or the "Company"), an innovator in sterilization technology for medical devices in healthcare settings, today announced that the nominees listed in the management proxy circular dated April 4, 2019, were elected as directors of TSO3. In addition, all other proposals submitted by management were approved.

Election of Directors

Based on the proxies received and the votes on a show of hands, the following individuals were elected as directors of the Company until the next annual shareholders' meeting. Accordingly, the results are set out below:

 

 

Name

Votes for

% for

Withheld

% withheld

Sara Elford

24,502,253

94.57

1,407,129

5.43

Martin J. Madden

24,219,590

93.48

1,689,792

6.52

Jeffrey Pompeo

21,019,592

81.13

4,889,790

18.87

Jean-Pierre Robert

21,213,336

81.88

4,696,046

18.12

Linda Rosentstock

21,714,350

83.81

4,195,032

16.19

Richard M. Rumble

20,395,438

78.72

5,513,944

21.28

Steve West

21,692,971

83.73

4,216,411

16.27

 

Other Proposals

 

 

Proposals

Votes for

% for

Withheld

% withheld

Appointment of Independent Auditors

27,794,707

87.17

4,089,764

12.83

 

Final voting results on all matters voted at the Annual Meeting of Shareholders held on May 7, 2019, will be filed on SEDAR (www.sedar.com) under the name TSO3.

About TSO3

Founded in 1998, TSO3's activities encompass the sale, production, maintenance, research, development and licensing of sterilization processes, related consumable supplies and accessories for heat-sensitive medical devices. The Company designs products for sterile processing areas in the hospital environment that offer an advantageous replacement solution to other low temperature sterilization processes currently used in hospitals. TSO3 also offers services related to the maintenance of sterilization equipment and compatibility testing of medical devices with such processes.

For more information about TSO3, visit the Company's website at www.tso3.com.

 

Cision

View original content:http://www.prnewswire.com/news-releases/tso3-announces-the-vote-results-from-its-annual-meeting-of-the-shareholders-300846418.html